Introduction to the Artificial Pancreas

The Artificial Pancreas revolutionizes diabetes management! It automates blood glucose control with cutting-edge tech. This game-changing system combines a continuous glucose monitor, an insulin pump, and a control algorithm to mimic the natural pancreas.

History and Development

Research kicked off in the 1970s and 1980s, but the 2000s saw major breakthroughs with continuous glucose monitoring systems. The first closed-loop system was tested in 2006, paving the way for innovation.

Technology and Innovation

Advanced algorithms analyze glucose levels and adjust insulin dosing in real-time. The system consists of three key components: a continuous glucose monitor, an insulin pump, and a control algorithm. Wireless communication enables seamless adjustments.

Manufacturers and Product Lines

Top companies like Medtronic, Tandem Diabetes Care, and Bigfoot Biomedical are driving Artificial Pancreas development. Medtronic's MiniMed 670G made history as the first FDA-approved closed-loop system in 2016. Tandem Diabetes Care's Control-IQ system followed suit in 2019.